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Heme-containing proteins form a vast and biologically impor-
tant superfamily: they are found in all living species and carry
out a very wide array of functions. The most well studied examples
are the O2 transport proteins (the globins), the electron transfer
proteins (the cytochromes), and the various catalytic enzymes,
the best characterized perhaps being the P450s, NO synthases
and the heme peroxidases. But beyond the scope of these ‘tradi-
tional’ heme proteins, there is now clear evidence of a wider regu-
latory role for heme in biological systems; examples include roles
for heme in ion channel regulation, transcriptional control and gas
sensing, but these roles are as yet only poorly deﬁned at a struc-
tural, mechanistic and functional level.
An important property of the heme group is the redox behavior
of the metal, which can exist in +2, +3 or +4 oxidation states. Across
the entire family of heme proteins, the stability of individual iron
oxidation states can vary enormously as a complex function of dif-
ferent variables including the nature, orientation and hydrogen
bonding interactions of the heme ligand(s), the identity of active
site residues around the heme group, solvent accessibility, the
heme substituents, the orientation of the heme group and vinylgroups, hydrogen bonding interactions of the heme propionates,
and the extent of heme rufﬂing (see for example [1–14]). The
reduction potential of the heme group is a key determinant of bio-
logical function, and yet reduction potentials for heme proteins are
not routinely reported, perhaps because the measurements have
often depended on specialist or somewhat inaccessible methodol-
ogies (see for example [15–27]). In this paper, we describe a simple
method for the determination of heme protein reduction poten-
tials. The method allows the determination of the reduction poten-
tial from equilibrium concentrations and without the need for
measuring a potential; it thus avoids some of the difﬁculties asso-
ciated with other electrochemical methods for the determinations
of reduction potentials in proteins, because equilibria are achieved
rapidly and there is no interference from surface contamination of
electrodes.
2. Materials and methods
2.1. Cloning of human NPAS2 and human CLOCK PAS domains
A construct of human NPAS2 (hNPAS2) corresponding to the
PAS-A domain (amino acids 78–240) was prepared from a cDNA
clone (Image clone # 5248433 from Source BioScience) and cloned
into an Escherichia coli expression vector (pLEICS-07) which
contains an N-terminal 6xHis-tag, an S-tag and a TEV protease
cleavage site upstream of the hNPAS2 PAS-A domain. A construct
2 One should, however, be aware of the drift of redox potentials of the reference
dye, which depends both on temperature and on pH (see Table S1 and Ref. [1]
therein).
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(amino acids 106–265) was cloned into an E. coli expression vector
separately (pLEICS-03), which contained an N-terminal 6xHis-tag
and a TEV protease cleavage site upstream of the hCLOCK PAS-A
domain, using cDNA clone (Origene). The sequencing of the
hNPAS2 and hCLOCK clones was carried out by the Protein and Nu-
cleic Acids Sequencing Laboratory (University of Leicester) and ver-
iﬁed using an Applied Biosystems 3730 sequencer.
2.2. Expression and puriﬁcation of hNPAS2 and hCLOCK constructs
E. coli Rosetta 2(DE3) cells transformed with either the hNPAS2
PAS-A/pLEICS-07 or hCLOCK PAS-A/pLEICS-03 plasmid were grown
in 2 YT media containing 30 lg/mL kanamycin at 37 C to an
optical density at 600 nm of 0.6–0.8. IPTG (200 lM) was then
added and the cells were incubated at 18 C overnight. Cells were
harvested by centrifugation at 5500g for 20 min. Cell pellets were
resuspended in lysis buffer (50 mM potassium phosphate pH 8,
300 mM potassium chloride, 10 mM imidazole) containing a prote-
ase inhibitor tablet (Roche), Lysozyme (Sigma–Aldrich) and DNAse
I (Sigma–Aldrich). Magnesium sulphate was added to a ﬁnal con-
centration of 20 mM and the cells lysed by sonication on ice at
8–10 microns for 30 s at a time, separated by 30 s intervals. The
cell lysate was then centrifuged at 38700g for 50 min and the
supernatant applied to a Ni-NTA column equilibrated with lysis
buffer. The column was washed with 300 mL wash buffer
(50 mM potassium phosphate pH 8, 300 mM potassium chloride,
20 mM imidazole) and protein eluted using 0.1 M EDTA pH 8. Con-
centrated protein was incubated at 4 C overnight with TEV prote-
ase to cleave the N-terminal tags and then passed down the Ni-
NTA column again to remove Tev protease and non-cleaved pro-
tein. The protein was then passed through a Ni-NTA column using
wash buffer and loaded onto a Superdex75 16/60 gel ﬁltration col-
umn equilibrated with 50 mM Tris, 50 mM potassium chloride, pH
7.5. The protein was puriﬁed in the apo form and reconstituted
with heme. Peaks were observed at 413 nm and 533 nm for both
hNPAS2 and CLOCK PAS-A in the UV–visible spectrum, which are
similar to those seen for mouse NPAS2 PAS-A [28] and mouse
CLOCK PAS-A [29]. Purity was assessed by SDS–PAGE and protein
was conﬁrmed to be the desired recombinant product by tryptic
digestion followed by MALDI-ToF mass spectrometry analysis.
2.3. Determination of reduction potentials
Reduction potentials were determined using a buffered solution
(50 mM potassium phosphate buffer, pH 7.0) containing the fol-
lowing constituents: xanthine as a source of electrons (30 mM
stock solution, stored at 20 C); protein (3–4 lM, to give an
absorbance in a suitable range (0.1–1.0)); a suitable dye with a
reduction potential close to that expected for the protein being
determined (lists of suggested dyes and their reduction potentials
are given in Table S1); catalase (10 mg/mL stock solution); a mix-
ture of glucose (1 M stock solution)/glucose oxidase (175 lM stock
solution), and xanthine oxidase (175 lM stock solution). In our
experiments, we ﬁrst add glucose (5 mM ﬁnal concentration), glu-
cose oxidase (50 lg/mL ﬁnal concentration), and xanthine (300 lM
ﬁnal concentration) to a solution of buffer to achieve O2-free con-
ditions [30]; we ﬁnd that the use of glucose/glucose oxidase is
effective in the removal of oxygen, in advance of adding enzyme
to the solution, and is more convenient than working under nitro-
gen/argon atmospheres (as Massey suggested [31]) or in a glove
box. Catalase (5 lg/mL ﬁnal concentration) is also added to the
above buffered solution to remove the hydrogen peroxide pro-
duced by the glucose oxidase. We ﬁnd that freshly made solutions
of catalase give more reliable results; this is especially important
when measuring reduction potentials of heme enzymes with highreactivity towards peroxide, to avoid adventitious formation of fer-
ryl heme prior to reduction of the heme to ferrous (although this
problem is eliminated as soon as the solution becomes anaerobic).
Protein and dye are then added to this solution, with the concen-
tration of the dye adjusted by titration to give an absorbance which
is approximately equal to that of the highest absorbance band in
the protein spectra. Finally, xanthine oxidase (50 nM ﬁnal concen-
tration) was added to initiate the two-electron oxidation of xan-
thine to uric acid and the corresponding reduction of protein and
dye. Absorbance changes corresponding to reduction of the heme
were measured at a wavelength where the contribution of the
dye was negligible compared to that of the protein (typically
400–420 nm, depending on the protein). Reduction of the dye
was measured in the 500–700 nm region, where the largest absor-
bance change for the dye was observed and the change in heme
absorption is negligible.
Spectra were collected (25.0 C) every minute over a period of
ca 40 min after the addition of xanthine oxidase (a fast scan rate
is needed for optimum results and to ensure consistency of con-
centration determinations at different wavelengths). When spectra
had remained constant for at least 10 min, sodium dithionite (an
excess of ca 5–10 mM) was added at the end of the reaction to ob-
tain an absorbance reading for the fully reduced protein, after
which spectra were collected until the absorbance values remained
constant for at least a further 5 min. Data were ﬁtted to a Nernst
plot, as derived and described in the Supplementary Material (Eq.
S6). All potentials are given versus a normal hydrogen electrode
(NHE).
3. Results
The method that we describe is a modiﬁcation of that described
by Massey [31]. It is conceptually and technically simplistic in the
sense that spectroscopic measurements are used to obtain the con-
centration ratio of the oxidized and reduced partners (protein and
dye), providing the equilibrium constant, which is related to poten-
tial via the Gibbs energy (using classical relationships, see Supple-
mentary material). The method allows the determination of the
reduction potential from equilibrium concentrations and without
the need for direct measurement of a potential (see [32] for a re-
cent historical perspective on early protein electrochemistry). We
found that we could reliably reproduce the reduction potential of
known proteins. Using toluidine blue O (Em = 34 mV, Table S1)
we determined a reduction potential for horse myoglobin
(Em = 47 mV ± 2 mV, pH 7.0, Fig. S1), which is close to the literature
value at the same pH [33] (literature values for horse myoglobin
vary slightly across a range of experimental conditions, reviewed
in [2]). Similarly, using disodium 2,6-dichlorophenolindophenol
(Em = 217 mV, Table S1), the reduction potential of cytochrome c
was determined as Em = 261 mV ± 2 mV (data not shown), which
compared well to literature values [34–39]. We ﬁnd that the meth-
odology is faster than other mediated [23,40–42] methods and
more convenient than direct electrochemistry methods [16], be-
cause electrons are exchanged in bulk solution instead of via med-
iated electron transfer between the protein and thin-layer
electrode, which means that equilibria are reached more quickly
(and avoids very long equilibration times), and the process is not
vulnerable to surface contamination. Since the method is based
on equilibration, in principle it can be used at any pH or tempera-
ture at which the proteins involved are stable and the correspond-
ing equilibration reactions occur at reasonable rates.2
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Fig. 1. (A) Spectroscopic changes observed during the determination of the Fe3+/2+
reduction potential of the PAS-A domain of hNPAS2 using the dye Nile blue (25.0 C,
pH 7.0). Arrows indicate direction of absorbance changes. (B) The corresponding
Nernst plot.
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Fig. 2. (A) Spectroscopic changes observed during the determination of the Fe3+/2+
reduction potential of the PAS-A domain of hCLOCK using the dye Nile blue (25.0 C,
pH 7.0). Arrows indicate direction of absorbance changes. (B) The corresponding
Nernst plot.
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potential for two related heme-binding regulatory proteins, human
NPAS2 and human CLOCK, both of which are implicated in regula-
tion of the circadian clock [43]. NPAS2 and CLOCK form heterodi-
mers with BMAL1 (brain and muscle Arnt-like 1) and the dimer
binds to an E-box DNA sequence (CANNTG) to activate expression
of the negative autoregulators, the Per and Cry genes [43]. Both
NPAS2 and CLOCK contain a DNA-binding helix-loop-helix motif
followed by two regulatory PAS domains (PAS-A and PAS-B), both
of which are thought to bind heme [28,44,45]. Using Nile Blue
(Em = 116 mV, Table S1), we determined the reduction potential
for the PAS-A domains of both human NPAS2 (Em =
115 mV ± 2 mV, pH 7.0, Fig. 1) and human CLOCK (Em =
111 mV ± 2 mV, pH 7.0, Fig. 2).
4. Discussion
In 1991, Massey published what was described as a simple
method for the determination of redox potentials [31]. The method
has since been very widely and routinely adopted in the determi-
nation of redox potentials of ﬂavins and ﬂavoproteins (a citation
search on Web of Science ﬁnds >100 citations to the Massey pa-
per). Although Massey himself noted the potential usefulness of
this method for determinations of reduction potentials in other re-
dox proteins, the fact that the original method focussed on one
group of proteins – those containing ﬂavin cofactors – seems to
have limited its widespread adoption, because application of themethod in the subsequent literature has been almost exclusively
limited to ﬂavin proteins. As we show in this paper, the method
can reliably reproduce literature reduction potentials of well-
known heme proteins, and we have also previously applied it to
other catalytic heme enzymes [23,46,47]. But we also ﬁnd that
the method is equally well applied to other, newer heme proteins
such as the regulatory heme proteins examined in this paper
(which often bind heme rather more weakly). Others have recently
found our approach useful [48], and we believe that the method
can be widely useful for most heme proteins.
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